Etan Marks, DO
6.3K posts

Etan Marks, DO
@et565
Dual-Trained Hemepath/Dermpath. Loving Husband and Father. Eccentrically Optimistic!


Two FDA approvals in hematologic malignancies today: 1-FDA approved the first all oral HMA + venetoclax regimen (decitabine/cedazuridine + venetoclax) for newly diagnosed AML patients unfit for intensive chemotherapy. 2-FDA also granted accelerated approval to sonrotoclax, a next generation BCL2 inhibitor, for relapsed/refractory mantle cell lymphoma after ≥2 prior lines including a BTK inhibitor












New review by Maria Gonzalez-Rellan & Daniel Drucker focuses on the expanding benefits of GLP-1 meds like semaglutide & tirzepatide. Beyond glucose/weight control: ↓ CVD events, CKD progression, MASLD, OA, sleep apnea (via anti-inflammatory paths) partly weight-loss independent. cell.com/cell-reports-m…



DNC committee shoots down resolution condemning AIPAC thehill.com/homenews/campa…
















